RNA, 7SL, cytoplasmic 155, pseudogene (RN7SL155P)

RN7SL155P is a pseudogene corresponding to the 7SL RNA family. Pseudogenes are genomic DNA sequences similar to normal genes but are nonfunctional; in this case, RN7SL155P lacks the ability to transcribe a functional RNA molecule and does not participate in cellular pathways such as those involving the signal recognition particle (SRP) mediated protein targeting[4][7][6]. The 7SL RNA is a well-conserved non-coding RNA forming the essential RNA scaffold of the signal recognition particle (SRP), a ribonucleoprotein complex critical for targeting proteins to the endoplasmic reticulum[1][3][5][8]. RN7SL155P is not among the few functional human 7SL RNA genes—such as RN7SL1, RN7SL2, or RN7SL3—but is part of the much more numerous group of 7SL RNA pseudogenes. These pseudogenes result from reverse transcription and integration events, but they are truncated and generally unexpressed, lacking known biological function[7]. There are no known disease roles, biological functions, or drug interactions associated with RN7SL155P—it is essentially "dead" DNA serving as a molecular fossil, and not a direct participant in physiology or pathology[4][7]. Pseudogenes such as RN7SL155P are often used as genomic markers or for evolutionary studies but are not considered therapeutic targets, receptors, or functional enzymes. Information specific to RN7SL155P is limited due to its classification as a pseudogene. Most functional insights and disease associations pertain to the canonical, functional 7SL RNA genes, not to the pseudogenes like RN7SL155P[4][7][6]. In summary, RN7SL155P is a nonfunctional pseudogene of the 7SL RNA family and does not represent a valid therapeutic target, receptor, or enzyme. All relevant biological and clinical information pertains to its functional paralogs, while RN7SL155P itself is typically unexpressed and of no direct biological or therapeutic interest[4][7][6].

Other names

RN7SL155P